Is severe hyponatremia most likely to occur in severe pre‑eclampsia compared with thrombotic thrombocytopenic purpura (TTP) or hemolytic‑uremic syndrome (HUS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Severe Hyponatremia is NOT Most Likely with Severe Pre-eclampsia

Severe hyponatremia is actually more characteristic of severe pre-eclampsia than TTP or HUS, though it remains an uncommon finding overall. While the provided evidence does not directly compare electrolyte abnormalities across these three conditions, the available data strongly suggests that hyponatremia has a specific association with severe pre-eclampsia that is not prominently described for TTP or HUS.

Evidence Supporting Hyponatremia in Severe Pre-eclampsia

The research evidence consistently demonstrates that hyponatremia occurs in pre-eclampsia, particularly in severe cases:

  • Prevalence: Hyponatremia (defined as sodium <130-135 mEq/L) occurs in approximately 9-15% of pre-eclamptic patients 1, 2, 3
  • Association with severity: Hyponatremia is strongly correlated with severe features of pre-eclampsia 4, 2, 3
  • Clinical significance: Patients with hyponatremia and pre-eclampsia more frequently require emergency antihypertensives (76.7% vs 67.4%), antenatal steroids (47.9% vs 35.5%), and cesarean delivery (12.6% vs 3.6%) 4

The most recent case report from 2026 describes profound hyponatremia (Na 118 mmol/L) in early-onset severe pre-eclampsia, emphasizing that this represents hypervolemic hyponatremia requiring multidisciplinary management 1.

Absence of Evidence for TTP and HUS

Critically, the provided guidelines on TTP 5 make no mention of hyponatremia as a diagnostic feature or complication. The TTP guideline focuses on:

  • Thrombocytopenia
  • Microangiopathic hemolytic anemia with schistocytes
  • Elevated LDH and indirect bilirubin
  • Low ADAMTS13 activity

Similarly, while HUS is mentioned in pregnancy contexts, there is no documentation of hyponatremia as a characteristic feature in the evidence provided.

Diagnostic Differentiation in Pregnancy

When differentiating these conditions during pregnancy, the TTP guideline notes that pre-eclampsia and HELLP syndrome are far more common than TTP or complement-mediated HUS 5. The key distinguishing features are:

Pre-eclampsia/HELLP:

  • Typically after mid-second trimester
  • Hypertension with proteinuria
  • May have hyponatremia
  • Resolves with delivery

TTP:

  • Can occur any time during pregnancy
  • Severe thrombocytopenia (often <50 × 10⁹/L)
  • ADAMTS13 activity <10%
  • Does NOT resolve with delivery alone
  • No specific mention of electrolyte abnormalities

HUS:

  • Predominantly third trimester/postpartum
  • Acute kidney injury prominent
  • Normal ADAMTS13 activity
  • No specific mention of hyponatremia

Clinical Implications

Monitor serum sodium in all patients with severe pre-eclampsia, especially those with:

  • Severe features present
  • Twin gestations 3
  • Early-onset disease (<34 weeks) 1
  • Pre-existing chronic kidney disease 1

Severe hyponatremia (<125 mEq/L) in pre-eclampsia should be managed with:

  • Fluid restriction as first-line
  • Hypertonic saline if sodium continues to decline 1, 6
  • Expedited delivery planning
  • Neonatal monitoring for hyponatremia 6

Important Caveat

The question asks which condition is "most likely" to have severe hyponatremia, but this may be misleading. Hyponatremia is documented and studied in pre-eclampsia but is not prominently featured in TTP or HUS literature. This doesn't necessarily mean it's more common in pre-eclampsia—it may simply reflect that it has been recognized and studied in that context. The absence of evidence is not evidence of absence. However, based on available clinical guidelines and research, hyponatremia appears to be a recognized complication specifically associated with severe pre-eclampsia 1, 4, 2, 3, while it is not mentioned as a characteristic feature of TTP or HUS in the provided evidence 5.

Related Questions

What is the appropriate workup for hyponatremia in a patient with preeclampsia?
How to manage hyponatremia (low sodium levels) caused by preeclampsia?
How should mild hyponatremia be corrected in a pregnant patient?
Was the management of a 33‑week gestation, day‑2 postpartum woman with severe pre‑eclampsia, gestational diabetes, and acute COVID‑19 infection—who presented with severe anasarca, uncontrolled hypertension, hypoxemia, required high‑flow nasal oxygen (HFNO), dexamethasone, broad‑spectrum antibiotics (ceftriaxone and azithromycin), antihypertensive therapy (methyldopa), orotracheal intubation, prone positioning, treatment for severe hyperkalemia, Foley catheter replacement, and nephrology‑guided care for acute tubular necrosis—consistent with current standard of care, and did any negligence, imprudence, lack of skill, therapeutic excess, or omission occur?
In a patient with severe preeclampsia and a serum potassium of 5.3 mmol/L, is telemetry monitoring indicated?
In a 64‑year‑old woman with a history of breast cancer who has a hepatic lesion in segment IV described as “suggestive of a cyst” on chest CT, what is the safest next step to characterize the lesion?
Should non‑pharmacologic airway‑clearance therapies such as incentive spirometry, EzPAP, or Acapella be implemented for the general skilled‑nursing‑facility population as part of a wellness program to prevent respiratory complications?
What is the recommended treatment for a hand arthritis flare‑up?
What are the common causes of intermenstrual spotting?
What are the causes and recommended treatments for dynamic tracheal collapse (tracheomalacia) in an infant?
What is the normal lactate-to-pyruvate (L/P) ratio in microdialysis and how are different ratio values interpreted regarding tissue oxygenation and ischemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.